EDGAR Filing Documents for 0001062993-22-012306

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001062993-22-012306

Filing Date

2022-05-12

Accepted

2022-05-12 20:27:47

Documents

Period of Report

2022-05-10

Document Format Files

Seq	Description	Document	Type	Size
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.html	4
1	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4.xml	4	3783
	Complete submission text file	0001062993-22-012306.txt		5379

Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142

Business Address

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 22919780

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004

Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations